切换至 "中华医学电子期刊资源库"

中华腔镜外科杂志(电子版) ›› 2019, Vol. 12 ›› Issue (02): 79 -81. doi: 10.3877/cma.j.issn.1674-6899.2019.02.004

所属专题: 文献资源库

论著 上一篇    下一篇

肺小结节胸腔镜解剖性肺段切除术初步报道
张彤 1, 马永富 1, 李云婧 1, 冯长江 1, 潘俊伊 1, 刘阳 1 , ( )   
  1. 1. 100853 北京,解放军总医院第一医学中心胸外科
  • 收稿日期:2019-03-12 出版日期:2019-04-30
  • 通信作者: 刘阳

Thoracoscopic anatomical pulmonary segmentectomy for pulmonary nodule

Tong Zhang 1, Yongfu Ma 1, Yunjing Li 1, Changjiang Feng 1, Junyi Pan 1, Yang Liu 1 , ( )   

  1. 1. Department of Thoracic Surgery, The First Medical Center of Chinese PLA General Hospital, Beijing 100853, China
  • Received:2019-03-12 Published:2019-04-30
  • Corresponding author: Yang Liu
  • About author:
    Corresponding author: Liu Yang, Email:
目的

探讨胸腔镜解剖性肺段切除术的可行性及安全性。

方法

回顾性分析解放军总医院第一医学中心胸外科2017年3月至2018年12月行胸腔镜解剖性肺段切除术的86例临床资料。手术均为3切口。对术后住院时间、术后并发症发生率等情况进行总结,对解剖性肺段切除术的现况、优势及适应证进行分析。

结果

86例患者顺利施行了胸腔镜解剖性肺段切除术,手术顺利,无中转开胸或改行肺叶切除病例。平均手术时间(160.59±42.43)min,平均术中出血量(27.06±1.23)ml,平均淋巴结清扫数量(6.78±3.54)枚,平均胸腔闭式引流管留置时间(4.84±2.12)d,平均术后住院时间(6.53±1.41)d。术后病理:腺癌78例,鳞状细胞癌1例,黏液腺癌1例,良性结节6例,其中原发非小细胞肺癌均为Ⅰa期。术后均未出现严重并发症、复发及死亡。

结论

解剖性肺段切除术创伤小、恢复快、术后住院时间短,其远期预后效果缺乏前瞻性数据支持,必须严格把控肺段切除术的适应证。

Objective

To investigate the feasibility and security of thoracoscopic anatomical pulmonary segmentectomy in the treatment of pulmonary nodule.

Methods

Department of thoracic surgery, The First Medical Center of Chinese PLA General Hospital From Mar. 2017 to Dec.2018, we performed thoracoscopic anatomical pulmonary segmentectomy for 86 patients. Three incisions were used in our procedure. The postoperative hospital stay and incidence of postoperative complication were carried out. The status, advantages and indications of thoracoscopic anatomical segmentectomy were analyzed.

Results

All the 86 patients underwent thoracoscopic anatomical pulmonary segmentectomy successfully without conversion to thoracotomy or lobectomy. The mean operation time was(160.59±42.43)min. The mean intraoperative blood loss was (27.06±1.23)ml. The mean number of lymph node dissections was(6.78±3.54). The chest tubes were maintained in position for(4.84±2.12)d. The mean postoperative hospital stay was (6.53±1.41)d. Postoperative pathological examination showed adenocarcinoma in 78 cases, squamous cell carcinoma in 1, mucinous adenocarcinoma in 1, benign nodule in 6 and the primary non-small cell lung cancer was classified as stageⅠa. No severe postoperative complications, death and local recurrence up to now.

Conclusions

Thoracoscopic anatomical pulmonary segmentectomy has the advantages of minimal trauma, fast recovery and short postoperative hospital stay. Its long-term prognosis is lack of prospective data support, so the indication of thoracoscopic anatomical pulmonary segmentectomy should be strictly controlled.

1
Migliore M, Fornito M, Palazzolo M, et al. Ground glass opacities management in the lung cancer screening era [J]. Ann Transl Med, 2018, 6(5): 90-90.
2
Jr MKR. Vats lobectomy with mediastinal lymph node sampling or dissection[J]. Chest Surg Clin N Am, 1995, 5(2):223-232.
3
Sugi K, Kobayashi S, Sudou M, et al. Long-term prognosis of video-assisted limited surgery for early lung cancer [J]. Eur J Cardiothorac Surg, 2010, 37(2): 456-460.
4
Oizumi H, Kanauchi N, Kato H, et al. Total thoracoscopic pulmonary segmentectomy [J]. Eur J Cardiothorac Surg, 2009, 36(2): 374-377.
5
Yamashita SI, Chujo M, Kawano Y, et al. Clinical impact of segmentectomy compared with lobectomy under complete video-assisted thoracic surgery in the treatment of stage i non-small cell lung cancer[J]. Journal of Surgical Research, 2011, 166(1):1-51.
6
林宗武,蒋伟,王群,等. 胸腔镜解剖性肺段切除术20例临床分析 [J]. 中国胸心血管外科临床杂志,2012, 19(3): 270-273.
7
Roviaro GC, Rebuffat C, Varoli F, et al. Videoendoscopic thoracic surgery [J]. Int Surg, 1993, 78(1): 4-9.
8
Smith CB, Swanson SJ, Mhango G, et al. Survival after segmentectomy and wedge resection in stage I non-small-cell lung cancer [J]. J Thorac Oncol, 2013, 8(1): 73-78.
9
Sienel W, Dango S, Kirschbaum A, et al. Sublobar resections in stage ia non-small cell lung cancer: segmentectomies result in significantly better cancer-related survival than wedge resections [J]. Eur J Cardiothorac Surg, 2008, 33(4): 728-734.
10
Okada M, Nishio W, Sakamoto T, et al. Effect of tumor size on prognosis in patients with non-small cell lung cancer: the role of segmentectomy as a type of lesser resection [J]. J Thorac Cardiovasc Surg, 2005, 129(1): 87-93.
11
Nakazawa S, Shimizu K, Mogi A, et al. VATS segmentectomy: past, present, and future [J]. Gen Thorac Cardiovasc Surg, 2018, 66(2): 81-90.
12
黄郴,林圣美,徐驯宇. 三维肺支气管血管重建模拟手术在胸腔镜肺段切除治疗早期肺癌中的应用 [J]. 临床外科杂志,2018, 26(3): 181-183.
13
刘瀚,陈亮,朱全,等. 完全胸腔镜下解剖性肺段切除术与肺叶切除术治疗肺部小结节的近期疗效比较[J/CD]. 中华临床医师杂志(电子版), 2012, 6(13): 3588-3591.
14
Zhang L, Li M, Yin R, et al. Comparison of the oncologic outcomes of anatomic segmentectomy and lobectomy for early-stage non-small cell lung cancer [J]. Ann Thorac Surg, 2015, 99(2): 728-737.
15
Nakamura K, Saji H, Nakajima R, et al. A phase Ⅲ randomized trial of lobectomy versus limited resection for small-sized peripheral non-small cell lung cancer (JCOG0802/WJOG4607L) [J]. Jpn J Clin Oncol, 2010, 40(3): 271-274.
16
陈亮,王俊,吴卫兵,等. 胸腔镜精准肺段切除术技术流程和质量控制 [J]. 中国胸心血管外科临床杂志,2019, 26(1): 21-28.
17
陈瑞骥,马永富,李宬润,等. 吲哚菁绿荧光染色右肺S2段切除术[J/CD]. 中华腔镜外科杂志(电子版), 2017, 10(4): 242-243.
[1] 王伟, 王坤, 孙涛, 茹玉航, 刘晓. 血清肝素结合蛋白、C-反应蛋白和降钙素原对肺癌电视胸腔镜术后肺部细菌感染的预测价值[J]. 中华实验和临床感染病杂志(电子版), 2021, 15(04): 257-262.
[2] 顾太梅, 钱叶本, 王丽, 赵欣婉, 王海进, 杨玲. 精准外科结合快速康复理念在肝癌术围术期处理中的应用[J]. 中华普外科手术学杂志(电子版), 2021, 15(04): 384-387.
[3] 韩焱楠, 李春磊, 李民华. 单孔胸腔镜手术治疗自发性气胸患者术后血气指标及生活质量的影响[J]. 中华肺部疾病杂志(电子版), 2021, 14(04): 459-461.
[4] 尉腊革, 李毅, 张建辉, 刘彦军, 李东迂, 栾中华. 单孔胸腔镜肺癌根治术后不同胸腔引流液量时拔管的康复分析[J]. 中华肺部疾病杂志(电子版), 2021, 14(04): 478-480.
[5] 汤俊, 刘占伟, 石明宏. 奥希替尼放疗对EGFR突变阳性NSCLC的临床分析[J]. 中华肺部疾病杂志(电子版), 2021, 14(04): 481-483.
[6] 周昌冬, 左小华, 单奔, 戚云凤. 血清miR-210、CY21-1联合多层螺旋CT诊断早期非小细胞肺癌临床意义[J]. 中华肺部疾病杂志(电子版), 2021, 14(04): 489-492.
[7] 吴勇, 陈健, 李成洁, 陈爱鸾, 沈伯雄. 不同浓度瑞芬太尼对胸腔镜下肺癌根治术患者围手术期免疫功能及肺功能的影响[J]. 中华肺部疾病杂志(电子版), 2021, 14(04): 508-510.
[8] 郑贝贝, 朱诺, 杨玖. EGFR-TKI联合胸部三维放疗治疗Ⅳ期非小细胞肺癌疗效分析[J]. 中华肺部疾病杂志(电子版), 2021, 14(04): 511-513.
[9] 曹路, 高宝安, 官莉, 陈世雄. 受体相互作用蛋白激酶4蛋白在组织中的表达NSCLC及其临床病理特征[J]. 中华肺部疾病杂志(电子版), 2021, 14(04): 517-519.
[10] 张倩, 高永恒, 郑开福, 金发光. 新辅助免疫治疗在手术可切除非小细胞肺癌中的研究进展[J]. 中华肺部疾病杂志(电子版), 2021, 14(04): 533-535.
[11] 农靖颖, 顾艳斐, 张毅. 晚期非小细胞肺癌免疫治疗预测生物标志物的研究进展[J]. 中华肺部疾病杂志(电子版), 2021, 14(04): 536-538.
[12] 陈燏, 王玉秀, 闵凌峰. NIX蛋白表达与非小细胞肺癌临床病理特征及预后[J]. 中华肺部疾病杂志(电子版), 2021, 14(04): 412-416.
[13] 郭俊唐, 王彬, 申磊磊, 梁朝阳, 刘阳. 胸腔镜前纵隔肿物切除术两种入路方式的对比分析[J]. 中华腔镜外科杂志(电子版), 2021, 14(04): 221-225.
[14] 薛兴阳, 蓝永权, 丁丹丹, 吴华振, 罗志明, 赵健. FOXA1在非小细胞肺癌组织中的表达及与癌转移相关性研究[J]. 中华临床实验室管理电子杂志, 2021, 09(03): 150-153.
[15] 徐韫健, 王建平, 林勇平, 姜桔红. 小体积核酸样本检测晚期非小细胞肺癌患者外周血表皮生长因子受体突变的可行性及应用[J]. 中华临床实验室管理电子杂志, 2021, 09(03): 164-168.
阅读次数
全文


摘要